Evidence map›Paper›PMID 32178975›Full record

SynthesisClinica chimica acta; international journal of clinical chemistry2020

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.

Giuseppe Lippi, Mario Plebani, Brandon Michael Henry

2 registry-linked trialsOpen access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Clinica chimica acta; international journal of clinical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 876 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
876citing papers in PubMed, 2 pooled it
41.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04470583 unknown statusnot on this map

Evaluation of Clinical Parameters Following COVID-19 Infection in Pregnancy (COpregVID)

TypeobservationalSponsorChelsea and Westminster NHS Foundation TrustRan2020 to 2021Enrolled116ConditionsCOVID-19, 2019 Novel Coronavirus Infection, COVID-19 Infection
NCT04668404 unknown statusnot on this map

Study of Coagulation Profile and Role of Heparin-like Effect in Patients With COVID-19

Typeobservational_patient_registrySponsorPost Graduate Institute of Medical Education and Research, ChandigarhRan2020 to 2021Enrolled50ConditionsCovid19, Hypercoagulable States NecArmsSonoclot
3 · Its place in the literature

Who cites it

876 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,786 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

816 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Giuseppe LippiSection of Clinical Biochemistry, Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona, Italy.
Mario PlebaniDepartment of Laboratory Medicine, University Hospital of Padova, Padova, Italy.
Brandon Michael HenryCardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, OH, USA. Electronic address: Brandon.henry@cchmc.org.
Cincinnati Children's Hospital Medical Center · USUniversity of Padua · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is a novel infectious disease with lack of established laboratory markers available to evaluate illness severity. In this study, we investigate whether platelet count could differentiate between COVID-19 patients with or without severe disease. Additionally, we evaluate if thrombocytopenia is associated with severe COVID-19.

methodsAn electronic search in Medline, Scopus and Web of Science was performed to identify studies reporting data on platelet count in COVID-19 patients. A meta-analysis was performed, with calculation of weighted mean difference (WMD) of platelet number in COVID-19 patients with or without severe disease and odds ratio (OR) of thrombocytopenia for severe form of COVID-19.

resultsNine studies with 1779 COVID-19 patients, 399 (22.4%) with severe disease, were included in the meta-analysis. The pooled analysis revealed that platelet count was significantly lower in patients with more severe COVID-19 (WMD -31 × 10

conclusionsLow platelet count is associated with increased risk of severe disease and mortality in patients with COVID-19, and thus should serve as clinical indicator of worsening illness during hospitalization.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19HumansPandemicsPlatelet CountPneumonia, ViralRisk FactorsSARS-CoV-2ThrombocytopeniaCoronavirus, COVID-19PlateletsThrombocytopenia

Identifiers

PMID32178975
PMCPMC7102663
OpenAlexW3012290165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.